Skip to main content
. 2020 May 27;9(3):1–11. doi: 10.1007/s40123-020-00261-x

Table 3.

Predicted IOL power for studied formulas based on pre-dilation and post-dilation measurements for method A (lowest myopic spheroequivalent residual refraction, LMP) and actual IOL power for studied formulas based on pre-dilation and post-dilation measurements for method B (ideal power for emmetropia, IPE)

IOL power formula Mean ± SD Mean difference 95% CI for mean difference p value
Pre-dilation Post-dilation
Method A
Barrett Universal II 19.68 ± 3.63 19.80 ± 3.64 0.123 ± 0.238 0.076, 0.169  < 0.001**
Olsen 19.65 ± 3.62 19.79 ± 3.61 0.142 ± 0.257 0.092, 0.193  < 0.001**
Hill-RBF 19.77 ± 3.65 19.86 ± 3.64 0.088 ± 0.238 0.042, 0.135  < 0.001**
Haigis 19.88 ± 3.71 19.99 ± 3.70 0.108 ± 0.250 0.059, 0.157  < 0.001**
Holladay I 19.80 ± 3.78 19.81 ± 3.77 0.010 ± 0.244 − 0.038, 0.058 0.26
SRK/T 19.78 ± 3.65 19.77 ± 3.63 − 0.010 ± 0.233 − 0.056, 0.036 0.81
Method B
Barrett Universal II 19.40 ± 3.58 19.43 ± 3.57 0.030 ± 0.215 − 0.013, 0.073 0.16
Olsen 19.39 ± 3.54 19.47 ± 3.53 0.076 ± 0.233 0.030, 0.123 0.002
Hill-RBF 19.49 ± 3.58 19.52 ± 3.58 0.021 ± 0.216 − 0.022, 0.064 0.35
Haigis 19.56 ± 3.63 19.61 ± 3.66 0.055 ± 0.259 0.003, 0.107 0.04
Holladay I 19.57 ± 3.74 19.57 ± 3.74 0.005 ± 0.213 − 0.038, 0.047 0.82
SRK/T 19.44 ± 3.57 19.45 ± 3.57 0.002 ± 0.189 − 0.035, 0.040 0.89

**p value confirmed with Wilcoxon signed-rank test